BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 29113730)

  • 1. Conversion to Resection in Patients Receiving Systemic Chemotherapy for Unresectable and/or Metastatic Colorectal Cancer-Predictive Factors and Prognosis.
    Nozawa H; Ishihara S; Kawai K; Hata K; Kiyomatsu T; Tanaka T; Nishikawa T; Otani K; Yasuda K; Sasaki K; Kaneko M; Murono K
    Clin Colorectal Cancer; 2018 Mar; 17(1):e91-e97. PubMed ID: 29113730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-front systemic chemotherapy is a feasible option compared to primary tumor resection followed by chemotherapy for colorectal cancer with unresectable synchronous metastases.
    Niitsu H; Hinoi T; Shimomura M; Egi H; Hattori M; Ishizaki Y; Adachi T; Saito Y; Miguchi M; Sawada H; Kochi M; Mukai S; Ohdan H
    World J Surg Oncol; 2015 Apr; 13():162. PubMed ID: 25908502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Conversion Chemotherapy for Secondary Surgical Resection in Colorectal Cancer Patients with Lung Metastases.
    Nozawa H; Ishihara S; Kawai K; Hata K; Kiyomatsu T; Tanaka T; Nishikawa T; Otani K; Yasuda K; Sasaki K; Murono K; Nakajima J; Watanabe T
    Oncology; 2017; 92(3):135-141. PubMed ID: 28052299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety, tolerability, and efficacy of oxaliplatin-based adjuvant chemotherapy after curative resection of hepatic or extrahepatic metastases of Stage IV colorectal cancer.
    Nakayama I; Suenaga M; Wakatsuki T; Ichimura T; Ozaka M; Takahari D; Shinozaki E; Chin K; Ueno M; Mizunuma N; Yamaguchi T
    Cancer Chemother Pharmacol; 2015 Jul; 76(1):133-9. PubMed ID: 25994854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy of liver resection after downsizing systemic chemotherapy for initially unresectable liver metastases.
    Kawamura J; Yazawa T; Sumida K; Kida Y; Ogawa R; Tani M; Kawasoe J; Yamamoto M; Harada H; Yamamoto H; Zaima M
    World J Surg Oncol; 2016 Feb; 14():56. PubMed ID: 26911142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical significance and efficacy of conversion surgery for patients with stage IV gastric cancer].
    Zhu Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1087-1092. PubMed ID: 30370504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical treatment options following chemotherapy plus cetuximab or bevacizumab in metastatic colorectal cancer-central evaluation of FIRE-3.
    Modest DP; Denecke T; Pratschke J; Ricard I; Lang H; Bemelmans M; Becker T; Rentsch M; Seehofer D; Bruns CJ; Gebauer B; Modest HI; Held S; Folprecht G; Heinemann V; Neumann UP
    Eur J Cancer; 2018 Jan; 88():77-86. PubMed ID: 29195117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Outcomes of Conversion Hepatectomy for Initially Unresectable Colorectal Liver Metastases.
    Maeda Y; Shinohara T; Nagatsu A; Futakawa N; Hamada T
    Ann Surg Oncol; 2016 Feb; 23 Suppl 2():S242-8. PubMed ID: 25749931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors for disease-free survival after preoperative chemotherapy followed by curative resection in patients with colorectal cancer harboring hepatic metastasis: a single-institute, retrospective analysis in Asia.
    Yi JH; Kim H; Jung M; Shin SJ; Choi JS; Choi GH; Baik SH; Min BS; Kim NK; Ahn JB
    Oncology; 2013; 85(5):283-9. PubMed ID: 24217184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary Metastases Resection After Bevacizumab Plus Irinotecan-Based Chemotherapy in First-Line Therapy of Metastatic Colorectal Cancer in a Real-Life Setting: Results of the ETNA Cohort.
    Rouyer M; Smith D; Laurent C; Becouarn Y; Guimbaud R; Michel P; Tubiana-Mathieu N; Balestra A; Jové J; Robinson P; Noize P; Moore N; Ravaud A; Fourrier-Réglat A;
    Target Oncol; 2016 Feb; 11(1):83-92. PubMed ID: 26298481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conversion chemotherapy followed by hepatic resection in colorectal cancer with initially unresectable liver-limited metastases.
    Galizia G; De Vita F; Lieto E; Zamboli A; Morgillo F; Castellano P; Mabilia A; Auricchio A; Renda A; Ciardiello F; Orditura M
    Oncol Rep; 2013 Dec; 30(6):2992-8. PubMed ID: 24126855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgery of the primary in stage IV colorectal cancer with unresectable metastases.
    Verhoef C; de Wilt JH; Burger JW; Verheul HM; Koopman M
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S61-6. PubMed ID: 21944031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Specific treatment situations in metastatic colorectal cancer].
    Arnold D; Schmoll HJ; Lang H; Knoefel WT; Ridwelski K; Trarbach T; Staib L; Kirchner T; Geissler M; Seufferlein T; Amthauer H; Riess H; Schlitt HJ; Piso P
    Onkologie; 2010; 33 Suppl 4():8-18. PubMed ID: 20431307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [HEMIHEPATECTOMY FOR RESECTABLE HEPATIC METASTASIS FROM COLORECTAL CANCER WITH POOR PROGNOSIS].
    Patyutko YI; Kotelnikov AG; Mamontov KG; Podluzhny DV; Ponomarenko AA
    Vopr Onkol; 2015; 61(3):439-47. PubMed ID: 26242159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver only metastatic disease in patients with metastatic colorectal cancer: impact of surgery and chemotherapy.
    Padman S; Padbury R; Beeke C; Karapetis CS; Bishnoi S; Townsend AR; Maddern G; Price TJ
    Acta Oncol; 2013 Nov; 52(8):1699-706. PubMed ID: 24102180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes after surgical resection in patients with stage IV colorectal cancer: a retrospective study of 129 patients at a single institution.
    Sudo M; Furuya S; Shimizu H; Nakata Y; Iino H; Shiraishi K; Akaike H; Hosomura N; Kawaguchi Y; Amemiya H; Kawaida H; Inoue S; Kono H; Ichikawa D
    World J Surg Oncol; 2019 Mar; 17(1):56. PubMed ID: 30904026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of oxaliplatin-based chemotherapy in curatively resected colorectal cancer with liver metastasis.
    Kim HR; Min BS; Kim JS; Shin SJ; Ahn JB; Rho JK; Kim NK; Rha SY
    Oncology; 2011; 81(3-4):175-83. PubMed ID: 22057187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential predictors of long-term survival after surgery for patients with stage IV colorectal cancer.
    Hotta T; Takifuji K; Arii K; Yokoyama S; Matsuda K; Higashiguchi T; Tominaga T; Oku Y; Yamaue H
    Anticancer Res; 2006; 26(2B):1377-83. PubMed ID: 16619547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative chemotherapy is associated with prognosis of stage IV colorectal cancer treated with preoperative chemotherapy/chemoradiotherapy and curative resection.
    Nozawa H; Sonoda H; Ishii H; Emoto S; Murono K; Kaneko M; Sasaki K; Nishikawa T; Shuno Y; Tanaka T; Kawai K; Hata K; Ishihara S
    Int J Colorectal Dis; 2020 Jan; 35(1):177-180. PubMed ID: 31807855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized phase II trial of three intensified chemotherapy regimens in first-line treatment of colorectal cancer patients with initially unresectable or not optimally resectable liver metastases. The METHEP trial.
    Ychou M; Rivoire M; Thezenas S; Quenet F; Delpero JR; Rebischung C; Letoublon C; Guimbaud R; Francois E; Ducreux M; Desseigne F; Fabre JM; Assenat E
    Ann Surg Oncol; 2013 Dec; 20(13):4289-97. PubMed ID: 23955585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.